Recurrent Urinary Tract Infection Prevention in Postmenopausal Women

Introduction to Prevention Strategies

The European Association of Urology recommends attempting interventions in a specific order, starting with counseling on risk factor avoidance and behavioral modifications, followed by non-antimicrobial measures, and finally antimicrobial prophylaxis if non-antimicrobial interventions fail 1, 3, 4

Vaginal estrogen is strongly recommended for rUTI prevention in postmenopausal women, with optimal efficacy at weekly doses of ≥850 µg, and should be administered topically 1, 2
The European Urology guidelines suggest that vaginal estrogen does not increase serum estrogen levels, avoiding systemic risks including breast cancer recurrence or endometrial hyperplasia 2

Methenamine hippurate can be used to reduce rUTI episodes in women without urinary tract abnormalities, with a dosing regimen of 1 gram twice daily, and can be combined with vaginal estrogen for additive effect 1, 5, 6
Immunoactive prophylaxis (OM-89/Uro-Vaxom) can be used to reduce rUTI in all age groups, with an oral immunostimulant that decreases rUTI (RR 0.61, 95% CI 0.48-0.78) and has a good safety profile 1, 6, 7
Lactobacillus-containing probiotics with proven efficacy for vaginal flora regeneration can be advised, with specific strains including Lactobacillus rhamnosus GR-1 or Lactobacillus reuteri RC-14, and can be used once or twice weekly for prophylaxis 1, 8

Continuous or postcoital antimicrobial prophylaxis should only be used after non-antimicrobial interventions have failed, with preferred agents including nitrofurantoin 50 mg daily, trimethoprim-sulfamethoxazole 40/200 mg daily, and trimethoprim 100 mg daily 1, 5, 8
Fluoroquinolones and cephalosporins should be avoided as first-line prophylaxis due to antimicrobial stewardship concerns, and antibiotics should be rotated at 3-month intervals to prevent antimicrobial resistance 8

Patients should be counseled on adequate hydration, voiding after intercourse, avoiding prolonged urine retention, controlling blood glucose in diabetics, avoiding spermicides, and avoiding harsh vaginal cleansers that disrupt normal flora 1, 8

Extensive routine workup (cystoscopy, full abdominal ultrasound) should not be performed in women younger than 40 years with rUTI and no risk factors, and asymptomatic bacteriuria should not be treated in women with rUTI, as this fosters antimicrobial resistance and increases rUTI episodes 1, 6, 10